Bioxcel Therapeutics, Inc. · NASDAQ:BTAI
Yocca Frank sold 6,845 Bioxcel Therapeutics, Inc. shares (Form 4)
Traded May 4 to May 20, 2026 · Filed May 22, 2026
From May 4 to May 20, 2026, Yocca Frank (Chief Scientific Officer) sold 6,845 Bioxcel Therapeutics, Inc. shares at US$1.09 for US$7,461 under a trading plan, leaving 26,175 shares. Filed May 22, 2026 (Form 4).
- Sold
- 6,845 shares
- Price
- US$1.09
- Value
- US$7,461
- Holding after
- 26,175 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 17,500 | 33,020 | Direct | |
| May 20, 2026 | Common Stock | Sale | 6,845 | US$1.09 | 26,175 | Direct |
Source
Related
- Bioxcel Therapeutics, Inc.
- Yocca Frank
- Bioxcel Therapeutics, Inc. shareholders
- Form 4 · Yocca Frank · Jun 17, 2026
- Form 4 · Yocca Frank · May 7, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Rodriguez Javier · Jun 17, 2026
- Form 4 · Steinhart Richard I · Jun 17, 2026
- Form 4 · Mehta Vimal · Jun 17, 2026
- Form 4 · Rodriguez Javier · May 22, 2026